US, India Agree To Share More Information On Opioid Trade
(Bloomberg) -- The US and India are looking to strengthen information sharing on the illegal trade of opioids such as fentanyl, to combat its misuse in the North American country.
Kristie Canegallo, acting deputy secretary at the US Department of Homeland Security, discussed the matter with her Indian counterparts at the Senior Officials' Homeland Security Dialogue in New Delhi on Wednesday. The exchange between law-enforcement agencies is part of the 2010 India-US counter-terrorism initiative.
“We talked about ways that we can build on our extensive information sharing,” particularly about fentanyl, Canegallo said in an interview. The two countries have an existing counter-narcotics working group.
Opioid misuse has long been an issue in the US. More than 100,000 people died of drug overdose in 2021 with synthetic opioids like fentanyl causing two-thirds of those deaths.
India legally produces opioids, including fentanyl, and exports them to the US. While Mexico and China are the primary sources of fentanyl and other related substances, including precursors, the US Drug Enforcement Agency has, in the past, highlighted India's role in the trafficking of some of these drugs into the US.
“We talked about the precursor drug, the precursor chemicals, and how we can be taking joint steps to try to disrupt those flows,” Canagello said about discussions with her Indian counterparts.
The US and China launched a joint anti-narcotics group to curb the production and trade of the highly addictive substance in January.
On countering terrorism, Canagello said India and the US discussed the rising threat of individuals radicalized by on-going conflicts and the continuing peril from organized terror groups.
“The dynamism and complexity of the threat landscape is higher today than it was 10 years ago or 20 years ago,” Canagello said, when asked about the potential for lone-wolf attacks affecting the US.
More stories like this are available on bloomberg.com
©2024 Bloomberg L.P.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.